United States Department of Veterans Affairs
Research Advisory Committee on Gulf War Veterans' Illnesses

Research Update - January 2007

 

The following journal articles were distributed for review in January 2007.  You can access the article's abstract by copying the paper title and pasting it into the search bar of the PubMed website, linked here. 


Research Relevant to Gulf War Service and Exposures
 
1. In harm’s way: infections in deployed American military forces.  (Aronson NE , et al.  Clin Infect Dis.  Oct 15, 2006; 43(8): 1045-1051)
 
2. Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody.  (Atta AM, et al.  J Autoimmun.  Jan 23, 2007; [Epub ahead of print])
 
3. Acetylcholinesterase inhibition affects cardiovascular structure in mice.  (Bernatova I, et al.  Physiol Res.  2006; 55 Suppl 1: S89-S97)
 
4. Psychological morbidity during the 2002 deployment to Afghanistan.  (Campion BH, et al.  J R Army Med Corps.  Jun 2006; 152(2): 91-93)
 
5. Motor neuron disorder simulating ALS induced by chronic inhalation of pyrethroid insecticides.  (Doi H, et al.  Neurology.  Nov 28, 2006; 67(10): 1894-1895)
 
6. The US Capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.  (Doolan DL, et al.  J Infect Dis.  Jan 15, 2007; 195(2): 174-184)
 
7. Altered pain processing in veterans with posttraumatic stress disorder.  (Geuze E, et al.  Arch Gen Psychiatry.  Jan 2007; 64(1): 76-85)
 
8. The effect of stress on the acute neurotoxicity of the organophosphate insecticide chlorpyrifos.  (Hancock S, et al.  Toxicol Appl Pharmacol.  Nov 16, 2006; [Epub ahead of print])
 
9. Association of posttraumatic stress disorder with somatic symptoms, health care visits, and absenteeism among Iraq War veterans.  (Hoge CW, et al.  Am J Psychiatry.  Jan 2007; 164(1): 150-153)
 
10. Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the Normative Aging Study.  (Kubzansky LD, et al.  Arch Gen Psychiatry.  Jan 2007; 64(1): 109-116)
 
11. The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women’s Heart and Health Study.  (Lawlor D, et al.  J Epidemiol Community Health.  Jan 2007; 61(1): 85-87)
 
12. Q fever in members of the United States armed forces returning from Iraq.  (Leung-Shea C, Danaher PJ.  Clin Infect Dis.  Oct 15, 2006; 43(8): e77-82)
 
13. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.  (Morahan JM, et al.  Neurotoxicology.  Nov 26, 2006; [Epub ahead of print])
 
14. Millenium Cohort: the 2001-2003 baseline prevalence of mental disorders in the U.S. military.  (Riddle JR, et al.  J Clin Epidemiol.  Feb 2007; 60(2): 192-201)
 
15. Women in novel occupational roles: mental health trends in the UK Armed Forces.  (Rona RJ, et al.  Int J Epidemiol.  Dec 15, 2006; [Epub ahead of print])
 
16. Millennium Cohort: enrollment begins a 21-year contribution to understanding the impact of military service.  (Ryan MA, et al.  J Clin Epidemiol.  Feb 2007; 60(2): 181-191)
 
17. Can low level exposure to ochratoxin-A cause parkinsonism?  (Sava V, et al.  J Neurol Sci.  Nov 1, 2006; 249(1): 68-75)
 
18. Prevalence of reported pain, widespread pain, and pain symmetry in veterans of the Persian Gulf War (1990-1991): the use of pain manikins in Persian Gulf War health research.  (Stimpson NJ , et al.  Mil Med.  Dec 2006; 171(12): 1181-1186)
 
19. Human brain structural change related to acute single exposure to sarin.  (Yamasue H, et al.  Ann Neurol.  Dec 22, 2006; [Epub ahead of print])
 

Research on the Evaluation and Treament of Chronic Multisymptom Illnesses
 
1. Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome.  (Alexander GM, et al.  Brain Behav Immun.  Nov 25, 2006; [Epub ahead of print])
 
2. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia.  (Hassett AL, et al.  Appl Psychophysiol Biofeedback.  Jan 12, 2007; [Epub ahead of print])
 
3. Growth hormone perturbations in fibromyalgia: a review.  (Jones KD, et al.  Semin Arthritis Rheum.  Jan 12, 2007; [Epub ahead of print])
 
4. Brain cytokines and the 5-HT system during poly 1:C-induced fatigue.  (Katafuchi T, et al.  Ann N Y Acad Sci.  Nov 2006; 1088: 230-237)
 
5. Acupuncture for fibromyalgia – a systematic review of randomized clinical trials.  (Mayhew E, Ernst E.  Rheumatology (Oxford ).  Dec 19, 2006; [Epub ahead of print])
 
6. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain:  findings of a population-based prospective cohort study.  (McBeth J, et al.  Arthritis Rheum.  Dec 28, 2006; 56(1): 360-371 [Epub ahead of print])
 
7. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.  (McLean SA, et al.  Neuropsychopharmacology.  Dec 2006; 31(12): 2776-2782.)
 
8. Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients.  (Nilsen KB, et al.  Eur J Pain.  Jan 13, 2007; [Epub ahead of print])
 
9. Erythrocyte oxidative damage in chronic fatigue syndrome.  (Richards RS, et al.  Arch Med Res.  Jan 2007; 38(1): 94-98)
 
10. Advances in treatment of complex regional pain syndrome: recent insights on a perplexing disease.  (Sharma A, et al.  Curr Opin Anaesthesiol  Oct 2006; 19(5): 566-572)
 
11. The low-dose dexamethasone suppression test in fibromyalgia.  (Wingenfeld K, et al.  J Psychosom Res.  Jan 2007; 62(1): 85-91)
 

Back to Previous Research Updates